WeLishibo-B opens higher, achieving dual breakthroughs in response rate and progression-free survival (PFS) for first-line non-small cell lung cancer (NSCLC) with its PD-L1/4-1BB bispecific antibody.Zhitong Finance · 15 Sep 2026
KBW Maintains Provident Financial Services(PFS.US) With Buy Rating, Raises Target Price to $28Market news · 3 Aug 2026
CanFang Bio (9926.HK): Final PFS results for HARMONI-3 are expected soon, with the company's platform‑based advantages becoming increasingly evident.Huatai Securities · 28 Aug 2026
Raymond James Maintains Provident Financial Services(PFS.US) With Buy Rating, Raises Target Price to $30Market news · 31 Jul 2026
Piper Sandler Maintains Provident Financial Services(PFS.US) With Buy Rating, Raises Target Price to $29Market news · 31 Jul 2026
D.A. Davidson Maintains Provident Financial Services(PFS.US) With Hold RatingMarket news · 31 Jul 2026
Piper Sandler Maintains Provident Financial Services(PFS.US) With Buy Rating, Raises Target Price to $26Market news · 30 Jul 2026
Heavy Minerals Ltd: Port Gregory PFS Delivers Maiden Ore Reserve - A$322.8M NPVASX · 29 Jul 2026
Raymond James Maintains Provident Financial Services(PFS.US) With Buy Rating, Raises Target Price to $27Market news · 1 Jul 2026
Stephens Initiates Provident Financial Services(PFS.US) With Hold Rating, Announces Target Price $24Market news · 8 Jun 2026
Goldman Sachs Initiates Provident Financial Services(PFS.US) With Buy Rating, Announces Target Price $41Market news · 1 Jun 2026
Many Peaks Minerals Ltd: A$27.5M Placement to Complete PFS and Extensive DrillingASX · 22 May 2026
KBW Maintains Provident Financial Services(PFS.US) With Buy Rating, Raises Target Price to $26Market news · 1 May 2026
No comments yet — be the first to weigh in on PFS.